Pharmaceutical Executive: February 2025 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.
At First Glance
Welcome to a bold new look for Pharmaceutical Executive's print and digital magazine.
2025 Pipeline Report: The Edge of Greatness?
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five expanding therapeutic areas.
Inclusive Marketing: Engaging with Purpose
How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreach
The benefits for brand teams in bolstering their rapid-response capability.
The Shifting Pharmacy Landscape in 2025
Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.
Navigating the EU’s Joint Clinical Assessment
Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.
Biopharma Business Check: Financing Review and Outlook
A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and biotech ahead.
Statistically and Clinically Significant Paths to Value Proposition
Demonstrating clinical benefit is the ultimate gateway to smoother patient access.
AI: Hungry for Power
The energy component—and cost—associated with artificial intelligence should not be overlooked in all the excitement.
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.
The Teva Turnaround: Steering a Company Comeback
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to recapture the heights of old.
